Adrenomedullin in the eye

Regulatory Peptides

Volumn 112, Issue 1-3, 2003, Pages 95-101

  Udono Fujimori, Reiko ^a   Udono, Tetsuo ^a   Totsune, Kazuhito ^a   Tamai, Makoto ^a   Shibahara, Shigeki ^a   Takahashi, Kazuhiro ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adrenomedullin; Pigment epithelium; Proliferative vitreoretinopathy; Retina

Indexed keywords

ADRENOMEDULLIN; CYTOKINE; DEXAMETHASONE; GLUCOCORTICOID; MESSENGER RNA;

CELL PROLIFERATION; CHORIORETINOPATHY; EYE DISEASE; GENE EXPRESSION REGULATION; HUMAN; HYPOXIA; IMMUNOREACTIVITY; INTRAOCULAR TUMOR; NONHUMAN; ORBIT TUMOR; PATHOGENESIS; PIGMENT CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; RETINA PIGMENT EPITHELIOPATHY; REVIEW; VITREORETINOPATHY; VITREOUS BODY;

EID: 12244275714     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(03)00027-2     Document Type: Review

References (71)

1. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y.et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.
2. Takahashi K., Brooks R.A., Kanse S.M., Ghatei M.A., Kohner E.M., Bloom S.R. Production of endothelin 1 by cultured bovine retinal endothelial cells and presence of endothelin receptors on associated pericytes. Diabetes. 38:1989;1200-1202.
3. Chakravarthy U., Douglas A.J., Bailie J.R., McKibben B., Archer D.B. Immunoreactive endothelin distribution in ocular tissues. Invest. Ophthalmol. Vis. Sci. 35:1994;2448-2454.
4. MacCumber M.W., Jampel H.D., Snyder S.H. Ocular effects of the endothelins. Abundant peptides in the eye. Arch. Ophthalmol. 109:1991;705-709.
5. Haefliger I.O., Flammer J., Luscher T.F. Nitric oxide and endothelin-1 are important regulators of human ophthalmic artery. Invest. Ophthalmol. Vis. Sci. 33:1992;2340-2343.
6. Takagi C., Bursell S.E., Lin Y.W., Takagi H., Duh E., Jiang Z.et al. Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1. Invest. Ophthalmol. Vis. Sci. 37:1996;2504-2518.
7. Taniguchi T., Okada K., Haque M.S., Sugiyama K., Kitazawa Y. Effects of endothelin-1 on intraocular pressure and aqueous humor dynamics in the rabbit eye. Curr. Eye Res. 13:1994;461-464.
8. Takagi H., Reinach P.S., Tachado S.D., Yoshimura N. Endothelin-mediated cell signaling and proliferation in cultured rabbit corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 35:1994;134-142.
9. Shoji N., Oshika T., Masuda K. Inflammatory reaction via arachidonic acid cascade after intravitreal injection of endothelin-1. Curr. Eye Res. 17:1998;205-210.
10. Shoji N., Oshika T., Amano S., Masuda K. Effects of endothelin receptor antagonists on anterior chamber inflammation induced by intravitreal injection of endothelin-1. Exp. Eye Res. 69:1999;437-444.
11. Chakrabarti S., Sima A.A. Endothelin-1 and endothelin-3-like immunoreactivity in the eyes of diabetic and non-diabetic BB/W rats. Diabetes Res. Clin. Pract. 37:1997;109-120.
12. Chakrabarti S., Gan X.T., Merry A., Karmazyn M., Sima A.A. Augmented retinal endothelin-1, endothelin-3, endothelinA and endothelinB gene expression in chronic diabetes. Curr. Eye Res. 17:1998;301-307.
13. Troger J., Neyer S., Heufler C., Huemer H., Schmid E., Griesser U.et al. Substance P and vasoactive intestinal polypeptide in the streptozotocin-induced diabetic rat retina. Invest. Ophthalmol. Vis. Sci. 42:2001;1045-1050.
14. Troger J., Kremser B., Irschick E., Gottinger W., Kieselbach G. Substance P in proliferative vitreoretinopathy: the significance of aqueous humor levels for evolution of the disease. Graefe Arch. Clin. Exp. Ophthalmol. 236:1998;900-903.
15. Troger J., Kremser B., Stockl T., Kralinger M., Schmid E., Kunze C.et al. Elevated levels of calcitonin gene-related peptide in aqueous humor of patients with proliferative vitreoretinopathy. Graefe Arch. Clin. Exp. Ophthalmol. 238:2000;237-242.
16. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H.et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 192:1993;553-560.
17. Kitamura K., Sakata J., Kangawa K., Kojima M., Matsuo H., Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem. Biophys. Res. Commun. 194:1993;720-725.
18. Hinson J.P., Kapas S., Smith D.M. Adrenomedullin, a multifunctional regulatory peptide. Endocr. Rev. 21:2000;138-167.
19. Takahashi K. Adrenomedullin from a pheochromocytoma to the eye: implications of the adrenomedullin research for endocrinology in the 21st century. Tohoku J. Exp. Med. 193:2001;79-114.
20. Takahashi K. Adrenomedullin: from a pheochromocytoma to the eyes. Peptides. 22:2001;1691.
21. Owji A.A., Smith D.M., Coppock H.A., Morgan D.G., Bhogal R., Ghatei M.A.et al. An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat. Endocrinology. 136:1995;2127-2134.
22. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N.et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature. 393:1998;333-339.
23. Montuenga L.M., Martinez A., Miller M.J., Unsworth E.J., Cuttitta F. Expression of adrenomedullin and its receptor during embryogenesis suggests autocrine or paracrine modes of action. Endocrinology. 138:1997;440-451.
24. Taniguchi T., Kawase K., Gu Z.B., Kimura M., Okano Y., Kawakami H.et al. Ocular effects of adrenomedullin. Exp. Eye Res. 69:1999;467-474.
25. Yousufzai S.Y., Ali N., Abdel-Latif A.A. Effects of adrenomedullin on cyclic AMP formation and on relaxation in iris sphincter smooth muscle. Invest. Ophthalmol. Vis. Sci. 40:1999;3245-3253.
26. Okamura T., Ayajiki K., Kangawa K., Toda N. Mechanism of adrenomedullin-induced relaxation in isolated canine retinal arteries. Invest. Ophthalmol. Vis. Sci. 38:1997;56-61.
27. Clementi G., Floriddia M.L., Prato A., Marino A., Drago F. Adrenomedullin and ocular inflammation in the rabbit. Eur. J. Pharmacol. 400:2000;321-326.
28. Udono T., Takahashi K., Takano S., Shibahara S., Tamai M. Elevated adrenomedullin in the vitreous of patients with proliferative vitreoretinopathy. Am. J. Ophthalmol. 128:1999;765-767.
29. Glaser B.M., Lemor M. Pathobiology of proliferative vitreoretinopathy. vol. 3:1994;2249-2263. St. Louis-Mosby.
30. Udono T., Takahashi K., Abe T., Shibahara S., Tamai M. Elevated immunoreactive-adrenomedullin levels in the aqueous humor of patients with uveitis and vitreoretinal disorders. Peptides. 23:2002;1865-1868.
31. Satoh F., Takahashi K., Murakami O., Totsune K., Sone M., Ohneda M.et al. Adrenomedullin in human brain, adrenal glands and tumor tissues of pheochromocytoma, ganglioneuroblastoma and neuroblastoma. J. Clin. Endocrinol. Metab. 80:1995;1750-1752.
32. Miller M.J., Martinez A., Unsworth E.J., Thiele C.J., Moody T.W., Elsasser T.et al. Adrenomedullin expression in human tumor cell lines. Its potential role as an autocrine growth factor. J. Biol. Chem. 271:1996;23345-23351.
33. Takahashi K., Satoh F., Hara E., Murakami O., Kumabe T., Tominaga T.et al. Production and secretion of adrenomedullin by cultured choroid plexus carcinoma cells. J. Neurochem. 68:1997;726-731.
34. Takahashi K., Satoh F., Hara E., Sone M., Murakami O., Kayama T.et al. Production and secretion of adrenomedullin from glial cell tumors and its effects on cAMP production. Peptides. 18:1997;1117-1124.
35. Nakayama M., Takahashi K., Murakami O., Shirato K., Shibahara S. Induction of adrenomedullin by hypoxia and cobalt chloride in human colorectal carcinoma cells. Biochem. Biophys. Res. Commun. 243:1998;514-517.
36. Udono T., Totsune K., Takahashi K., Abe T., Sato M., Shibahara S.et al. Increased expression of adrenomedullin mRNA in the tissues of intraocular and orbital tumors. Am. J. Ophthalmol. 129:2000;555-556.
37. Withers D.J., Coppock H.A., Seufferlein T., Smith D.M., Bloom S.R., Rozengurt E. Adrenomedullin stimulates DNA synthesis and cell proliferation via elevation of cAMP in Swiss 3T3 cells. FEBS Lett. 378:1996;83-87.
38. Udono T., Takahashi K., Nakayama M., Murakami O., Durlu Y.K., Tamai M., Shibahara S. Adrenomedullin in cultured human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 41:2000;1962-1970.
39. Limb G.A., Alam A., Earley O., Green W., Chignell A.H., Dumonde D.C. Distribution of cytokine proteins within epiretinal membranes in proliferative vitreoretinopathy. Curr. Eye Res. 13:1994;791-798.
40. Osusky R., Tao L., Ryan S.J. Interleukin 1 in experimental proliferative vitreoretinopathy. Ophthalmologica. 211:1997;49-52.
41. Kon C.H., Occleston N.L., Aylward G.W., Khaw P.T. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study. Invest. Ophthalmol. Vis. Sci. 40:1999;705-712.
42. Garayoa M., Martinez A., Lee S., Pio R., An W.G., Neckers L.et al. Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis. Mol. Endocrinol. 14:2000;848-862.
43. Kitamuro T., Takahashi K., Nakayama M., Murakami O., Hida W., Shirato K.et al. Induction of adrenomedullin during hypoxia in cultured human glioblastoma cells. J. Neurochem. 75:2000;1826-1833.
44. Kitamuro T., Takahashi K., Totsune K., Nakayama M., Murakami O., Hida W.et al. Differential expression of adrenomedullin and its receptor component, receptor activity modifying protein (RAMP) 2 during hypoxia in cultured human neuroblastoma cells. Peptides. 22:2001;1795-1801.
45. Cormier-Regard S., Nguyen S.V., Claycomb W.C. Adrenomedullin gene expression is developmentally regulated and induced by hypoxia in rat ventricular cardiac myocytes. J. Biol. Chem. 273:1998;17787-17792.
46. Nakayama M., Takahashi K., Murakami O., Shirato K., Shibahara S. Induction of adrenomedullin by hypoxia in cultured human coronary artery endothelial cells. Peptides. 20:1999;769-772.
47. Udono T., Takahashi K., Nakayama M., Yoshinoya A., Totsune K., Murakami O.et al. Induction of adrenomedullin by hypoxia in cultured retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 42:2001;1080-1086.
48. Satoh F., Takahashi K., Murakami O., Totsune K., Sone M., Ohneda M.et al. Immunocytochemical localization of adrenomedullin-like immunoreactivity in the human hypothalamus and the adrenal gland. Neurosci. Lett. 203:1996;207-210.
49. Takahashi K., Nakayama M., Totsune K., Murakami O., Sone M., Kitamuro T.et al. Increased secretion of adrenomedullin from cultured human astrocytes by cytokines. J. Neurochem. 74:2000;99-103.
50. Wang X., Yue T.L., Barone F.C., White R.F., Clark R.K., Willette R.N.et al. Discovery of adrenomedullin in rat ischemic cortex and evidence for its role in exacerbating focal brain ischemic damage. Proc. Natl. Acad. Sci. U. S. A. 92:1995;11480-11484.
51. Serrano J., Alonso D., Encinas J.M., Lopez J.C., Fernandez A.P., Castro-Blanco S.et al. Adrenomedullin expression is up-regulated by ischemia-reperfusion in the cerebral cortex of the adult rat. Neuroscience. 109:2002;717-731.
52. Bernaudin M., Tang Y., Reilly M., Petit E., Sharp F.R. Brain genomic response following hypoxia and re-oxygenation in the neonatal rat: identification of genes that might contribute to hypoxia-induced ischemic tolerance. J. Biol. Chem. 277:2002;39728-39738.
53. Gassmann M., Fandrey J., Bichet S., Wartenberg M., Marti H.H., Bauer C.et al. Oxygen supply and oxygen-dependent gene expression in differentiating embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 93:1996;2867-2872.
54. Caron K.M., Smithies O. Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional Adrenomedullin gene. Proc. Natl. Acad. Sci. U. S. A. 98:2001;615-619.
55. Shindo T., Kurihara Y., Nishimatsu H., Moriyama N., Kakoki M., Wang Y.et al. Vascular abnormalities and elevated blood pressure in mice lacking adrenomedullin gene. Circulation. 104:2001;1964-1971.
56. Kapas S., Brown D.W., Farthing P.M., Hagi-Pavli E. Adrenomedullin has mitogenic effects on human oral keratinocytes: involvement of cyclic AMP. FEBS Lett. 418:1997;287-290.
57. Kano H., Kohno M., Yasunari K., Yokokawa K., Horio T., Ikeda M.et al. Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells. J. Hypertens. 14:1996;209-213.
58. Chini E.N., Choi E., Grande J.P., Burnett J.C., Dousa T.P. Adrenomedullin suppresses mitogenesis in rat mesangial cells via cAMP pathway. Biochem. Biophys. Res. Commun. 215:1995;868-873.
59. Jonas J.B., Jochen K.H., Panda-Jonas S. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy. Br. J. Ophthalmol. 84:2000;1064-1067.
60. Jonas J.B., Hayler J.K., Sofker A., Panda-Jonas S. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy. Am. J. Ophthalmol. 131:2001;468-471.
61. Imai T., Hirata Y., Iwashina M., Marumo F. Hormonal regulation of rat adrenomedullin gene in vasculature. Endocrinology. 136:1995;1544-1548.
62. Minamino N., Shoji H., Sugo S., Kangawa K., Matsuo H. Adrenocortical steroids, thyroid hormones and retinoic acid augment the production of adrenomedullin in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 211:1995;686-693.
63. Kubo A., Minamino N., Isumi Y., Katafuchi T., Kangawa K., Dohi K.et al. Production of adrenomedullin in macrophage cell line and peritoneal macrophage. J. Biol. Chem. 273:1998;16730-16738.
64. Dunn K.C., Aotaki-Keen A.E., Putkey F.R., Hjelmeland L.M. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp. Eye Res. 62:1996;155-169.
65. Davis A.A., Bernstein P.S., Bok D., Turner J., Nachtigal M., Hunt R.C. A human retinal pigment epithelial cell line that retains epithelial characteristics after prolonged culture. Invest. Ophthalmol. Vis. Sci. 36:1995;955-964.
66. Uyama M., Matsunaga H., Matsubara T., Fukushima I., Takahashi K., Nishimura T. Indocyanine green angiography and pathophysiology of multifocal posterior pigment epitheliopathy. Retina. 19:1999;12-21.
67. Lin J.M., Tsai Y.Y. Retinal pigment epithelial detachment in the fellow eye of a patient with unilateral central serous chorioretinopathy treated with steroid. Retina. 21:2001;377-379.
68. Gass J.D.M., Little H. Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy. Ophthalmology. 102:1995;737-747.
69. Song E., Wakakura M., Ishikawa S. Central serous chorioretinopathy induced by corticosteroids. Nippon Ganka Gakkai Zasshi. 101:1997;257-264.
70. Chu D.Q., Smith D.M., Brain S.D. Studies of the microvascular effects of adrenomedullin and related peptides. Peptides. 22:2001;1881-1886.
71. Kato H., Shichiri M., Marumo F., Hirata Y. Adrenomedullin as an autocrine/paracrine apoptosis survival factor for rat endothelial cells. Endocrinology. 138:1997;2615-2620.